Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030947.pdf 0000899243-18-030947.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030945.pdf 0000899243-18-030945.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030948.pdf 0000899243-18-030948.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030951.pdf 0000899243-18-030951.rtf View HTML
December 13, 2018	4	Statement of changes in beneficial ownership of securities	0000899243-18-030952.pdf 0000899243-18-030952.rtf View HTML
December 20, 2018	8-K/A	Amendment to a previously filed 8-K	0001193125-18-353775.pdf 0001193125-18-353775.rtf 0001193125-18-353775.xls View HTML
December 21, 2018	SC 13D/A	An amendment to a SC 13D filing	0001144204-18-066059.pdf 0001144204-18-066059.rtf 0001144204-18-066059.xls View HTML
January 7, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-003178.pdf 0001193125-19-003178.rtf 0001193125-19-003178.xls View HTML
January 7, 2019	SC 13G/A	An amendment to the SC 13G filing	0001193125-19-003657.pdf 0001193125-19-003657.rtf 0001193125-19-003657.xls View HTML
January 9, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001567619-19-000883.pdf 0001567619-19-000883.rtf 0001567619-19-000883.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax